APO Research
Talk to an analyst

APO RESEARCH · REPORT

Aminoglycosides Antibiotics Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Aminoglycosides Antibiotics Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026190 pages

Choose your research edition.

Industry ResearchAminoglycosides Antibiotics Drug Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Aminoglycosides Antibiotics Drug Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Aminoglycosides Antibiotics Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Aminoglycosides Antibiotics Drug Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Aminoglycosides Antibiotics Drug Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Aminoglycosides Antibiotics Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Aminoglycosides Antibiotics Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Aminoglycosides Antibiotics Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Aminoglycosides Antibiotics Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Aminoglycosides Antibiotics Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Aminoglycosides Antibiotics Drug include Teva, Novartis, Pfizer, Fresenius Kabi, Sun Pharma, Lannett Company, Jemicare, Hikma and Fangyuan-pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Aminoglycosides Antibiotics Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Aminoglycosides Antibiotics Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Aminoglycosides Antibiotics Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Aminoglycosides Antibiotics Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Aminoglycosides Antibiotics Drug Segment by Company

Teva

Novartis

Pfizer

Fresenius Kabi

Sun Pharma

Lannett Company

Jemicare

Hikma

Fangyuan-pharma

Cipla

Aike Pharmaceutical

Aminoglycosides Antibiotics Drug Segment by Type

Etimicin

Neomycin

Tobramycin

Gentamicin

Amikacin

Others

Aminoglycosides Antibiotics Drug Segment by Application

Hospital

Clinic

Others

Aminoglycosides Antibiotics Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aminoglycosides Antibiotics Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Aminoglycosides Antibiotics Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aminoglycosides Antibiotics Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Aminoglycosides Antibiotics Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Aminoglycosides Antibiotics Drug industry.

Chapter 3: Detailed analysis of Aminoglycosides Antibiotics Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Aminoglycosides Antibiotics Drugrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Aminoglycosides Antibiotics Drug Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Etimicin Table 3. Key Players of Neomycin Table 4. Key Players of Tobramycin Table 3. Key Players of Gentamicin Table 4. Key Players of Amikacin Table 5. Key Players of Others Table 6. Global Aminoglycosides Antibiotics Drug Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 7. Key Players of Hospital Table 8. Key Players of Clinic Table 9. Key Players of Others Table 10. Global Aminoglycosides Antibiotics Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Aminoglycosides Antibiotics Drug Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Aminoglycosides Antibiotics Drug Market Share by Region (2021-2026) Table 13. Global Aminoglycosides Antibiotics Drug Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Aminoglycosides Antibiotics Drug Market Share by Region (2027-2032) Table 15. Aminoglycosides Antibiotics Drug Industry Trends Table 16. Aminoglycosides Antibiotics Drug Industry Drivers Table 17. Aminoglycosides Antibiotics Drug Industry Opportunities and Challenges Table 18. Aminoglycosides Antibiotics Drug Industry Restraints Table 19. Global Aminoglycosides Antibiotics Drug Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Aminoglycosides Antibiotics Drug Revenue Market Share by Company (2021-2026) Table 21. Global Aminoglycosides Antibiotics Drug Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Aminoglycosides Antibiotics Drug Key Company Head Office and Area Served Table 23. Global Aminoglycosides Antibiotics Drug Company, Product Type & Application Table 24. Global Aminoglycosides Antibiotics Drug Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Aminoglycosides Antibiotics Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Aminoglycosides Antibiotics Drug Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Aminoglycosides Antibiotics Drug Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Aminoglycosides Antibiotics Drug Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Aminoglycosides Antibiotics Drug Revenue Market Share by Type (2021-2026) Table 31. Global Aminoglycosides Antibiotics Drug Revenue Market Share by Type (2027-2032) Table 32. Global Aminoglycosides Antibiotics Drug Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Aminoglycosides Antibiotics Drug Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Aminoglycosides Antibiotics Drug Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Aminoglycosides Antibiotics Drug Revenue Market Share by Application (2021-2026) Table 36. Global Aminoglycosides Antibiotics Drug Revenue Market Share by Application (2027-2032) Table 37. Teva Company Information Table 38. Teva Business Overview Table 39. Teva Aminoglycosides Antibiotics Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Teva Aminoglycosides Antibiotics Drug Product Portfolio Table 41. Teva Recent Development Table 42. Novartis Company Information Table 43. Novartis Business Overview Table 44. Novartis Aminoglycosides Antibiotics Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Novartis Aminoglycosides Antibiotics Drug Product Portfolio Table 46. Novartis Recent Development Table 47. Pfizer Company Information Table 48. Pfizer Business Overview Table 49. Pfizer Aminoglycosides Antibiotics Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Pfizer Aminoglycosides Antibiotics Drug Product Portfolio Table 51. Pfizer Recent Development Table 52. Fresenius Kabi Company Information Table 53. Fresenius Kabi Business Overview Table 54. Fresenius Kabi Aminoglycosides Antibiotics Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Fresenius Kabi Aminoglycosides Antibiotics Drug Product Portfolio Table 56. Fresenius Kabi Recent Development Table 57. Sun Pharma Company Information Table 58. Sun Pharma Business Overview Table 59. Sun Pharma Aminoglycosides Antibiotics Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Sun Pharma Aminoglycosides Antibiotics Drug Product Portfolio Table 61. Sun Pharma Recent Development Table 62. Lannett Company Company Information Table 63. Lannett Company Business Overview Table 64. Lannett Company Aminoglycosides Antibiotics Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Lannett Company Aminoglycosides Antibiotics Drug Product Portfolio Table 66. Lannett Company Recent Development Table 67. Jemicare Company Information Table 68. Jemicare Business Overview Table 69. Jemicare Aminoglycosides Antibiotics Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Jemicare Aminoglycosides Antibiotics Drug Product Portfolio Table 71. Jemicare Recent Development Table 72. Hikma Company Information Table 73. Hikma Business Overview Table 74. Hikma Aminoglycosides Antibiotics Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Hikma Aminoglycosides Antibiotics Drug Product Portfolio Table 76. Hikma Recent Development Table 77. Fangyuan-pharma Company Information Table 78. Fangyuan-pharma Business Overview Table 79. Fangyuan-pharma Aminoglycosides Antibiotics Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Fangyuan-pharma Aminoglycosides Antibiotics Drug Product Portfolio Table 81. Fangyuan-pharma Recent Development Table 82. Cipla Company Information Table 83. Cipla Business Overview Table 84. Cipla Aminoglycosides Antibiotics Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Cipla Aminoglycosides Antibiotics Drug Product Portfolio Table 86. Cipla Recent Development Table 87. Aike Pharmaceutical Company Information Table 88. Aike Pharmaceutical Business Overview Table 89. Aike Pharmaceutical Aminoglycosides Antibiotics Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Aike Pharmaceutical Aminoglycosides Antibiotics Drug Product Portfolio Table 91. Aike Pharmaceutical Recent Development Table 92. North America Aminoglycosides Antibiotics Drug Market Size by Type (2021-2026) & (US$ Million) Table 93. North America Aminoglycosides Antibiotics Drug Market Size by Type (2027-2032) & (US$ Million) Table 94. North America Aminoglycosides Antibiotics Drug Market Size by Application (2021-2026) & (US$ Million) Table 95. North America Aminoglycosides Antibiotics Drug Market Size by Application (2027-2032) & (US$ Million) Table 96. North America Aminoglycosides Antibiotics Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. North America Aminoglycosides Antibiotics Drug Market Size by Country (2021-2026) Table 98. North America Aminoglycosides Antibiotics Drug Market Size by Country (2027-2032) Table 99. Europe Aminoglycosides Antibiotics Drug Market Size by Type (2021-2026) & (US$ Million) Table 100. Europe Aminoglycosides Antibiotics Drug Market Size by Type (2027-2032) & (US$ Million) Table 101. Europe Aminoglycosides Antibiotics Drug Market Size by Application (2021-2026) & (US$ Million) Table 102. Europe Aminoglycosides Antibiotics Drug Market Size by Application (2027-2032) & (US$ Million) Table 103. Europe Aminoglycosides Antibiotics Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Europe Aminoglycosides Antibiotics Drug Market Size by Country (2021-2026) Table 105. Europe Aminoglycosides Antibiotics Drug Market Size by Country (2027-2032) Table 106. China Aminoglycosides Antibiotics Drug Market Size by Type (2021-2026) & (US$ Million) Table 107. China Aminoglycosides Antibiotics Drug Market Size by Type (2027-2032) & (US$ Million) Table 108. China Aminoglycosides Antibiotics Drug Market Size by Application (2021-2026) & (US$ Million) Table 109. China Aminoglycosides Antibiotics Drug Market Size by Application (2027-2032) & (US$ Million) Table 110. Asia Aminoglycosides Antibiotics Drug Market Size by Type (2021-2026) & (US$ Million) Table 111. Asia Aminoglycosides Antibiotics Drug Market Size by Type (2027-2032) & (US$ Million) Table 112. Asia Aminoglycosides Antibiotics Drug Market Size by Application (2021-2026) & (US$ Million) Table 113. Asia Aminoglycosides Antibiotics Drug Market Size by Application (2027-2032) & (US$ Million) Table 114. Asia Aminoglycosides Antibiotics Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. Asia Aminoglycosides Antibiotics Drug Market Size by Country (2021-2026) Table 116. Asia Aminoglycosides Antibiotics Drug Market Size by Country (2027-2032) Table 117. South America, Middle East & Africa Aminoglycosides Antibiotics Drug Market Size by Type (2021-2026) & (US$ Million) Table 118. South America, Middle East & Africa Aminoglycosides Antibiotics Drug Market Size by Type (2027-2032) & (US$ Million) Table 119. South America, Middle East & Africa Aminoglycosides Antibiotics Drug Market Size by Application (2021-2026) & (US$ Million) Table 120. South America, Middle East & Africa Aminoglycosides Antibiotics Drug Market Size by Application (2027-2032) & (US$ Million) Table 121. South America, Middle East & Africa Aminoglycosides Antibiotics Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. South America, Middle East & Africa Aminoglycosides Antibiotics Drug Market Size by Country (2021-2026) Table 123. South America, Middle East & Africa Aminoglycosides Antibiotics Drug Market Size by Country (2027-2032) Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Aminoglycosides Antibiotics Drug Product Image Figure 2. Global Aminoglycosides Antibiotics Drug Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Aminoglycosides Antibiotics Drug Market Share by Type: 2025 VS 2032 Figure 4. Etimicin Image Figure 5. Neomycin Image Figure 6. Tobramycin Image Figure 7. Gentamicin Image Figure 8. Amikacin Image Figure 9. Others Image Figure 10. Global Aminoglycosides Antibiotics Drug Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 11. Global Aminoglycosides Antibiotics Drug Market Share by Application: 2025 VS 2032 Figure 12. Hospital Image Figure 13. Clinic Image Figure 14. Others Image Figure 15. Global Aminoglycosides Antibiotics Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Aminoglycosides Antibiotics Drug Market Size (2021-2032) & (US$ Million) Figure 17. Global Aminoglycosides Antibiotics Drug Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Aminoglycosides Antibiotics Drug Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Aminoglycosides Antibiotics Drug Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Aminoglycosides Antibiotics Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Aminoglycosides Antibiotics Drug Revenue Market Share by Type (2021-2032) Figure 24. Global Aminoglycosides Antibiotics Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Aminoglycosides Antibiotics Drug Revenue Market Share by Application (2021-2032) Figure 26. North America Aminoglycosides Antibiotics Drug Market Size (2021-2032) & (US$ Million) Figure 27. North America Aminoglycosides Antibiotics Drug Market Share by Type (2021-2032) Figure 28. North America Aminoglycosides Antibiotics Drug Market Share by Application (2021-2032) Figure 29. North America Aminoglycosides Antibiotics Drug Market Share by Country (2021-2032) Figure 30. United States Aminoglycosides Antibiotics Drug Market Size (2021-2032) & (US$ Million) Figure 31. Canada Aminoglycosides Antibiotics Drug Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Aminoglycosides Antibiotics Drug Market Size (2021-2032) & (US$ Million) Figure 33. Europe Aminoglycosides Antibiotics Drug Market Size (2021-2032) & (US$ Million) Figure 34. Europe Aminoglycosides Antibiotics Drug Market Share by Type (2021-2032) Figure 35. Europe Aminoglycosides Antibiotics Drug Market Share by Application (2021-2032) Figure 36. Europe Aminoglycosides Antibiotics Drug Market Share by Country (2021-2032) Figure 37. Germany Aminoglycosides Antibiotics Drug Market Size (2021-2032) & (US$ Million) Figure 38. France Aminoglycosides Antibiotics Drug Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Aminoglycosides Antibiotics Drug Market Size (2021-2032) & (US$ Million) Figure 40. Italy Aminoglycosides Antibiotics Drug Market Size (2021-2032) & (US$ Million) Figure 41. Russia Aminoglycosides Antibiotics Drug Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Aminoglycosides Antibiotics Drug Market Size (2021-2032) & (US$ Million) Figure 43. China Aminoglycosides Antibiotics Drug Market Size (2021-2032) & (US$ Million) Figure 44. China Aminoglycosides Antibiotics Drug Market Share by Type (2021-2032) Figure 45. China Aminoglycosides Antibiotics Drug Market Share by Application (2021-2032) Figure 46. Asia Aminoglycosides Antibiotics Drug Market Size (2021-2032) & (US$ Million) Figure 47. Asia Aminoglycosides Antibiotics Drug Market Share by Type (2021-2032) Figure 48. Asia Aminoglycosides Antibiotics Drug Market Share by Application (2021-2032) Figure 49. Asia Aminoglycosides Antibiotics Drug Market Share by Country (2021-2032) Figure 50. Japan Aminoglycosides Antibiotics Drug Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Aminoglycosides Antibiotics Drug Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Aminoglycosides Antibiotics Drug Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Aminoglycosides Antibiotics Drug Market Size (2021-2032) & (US$ Million) Figure 54. India Aminoglycosides Antibiotics Drug Market Size (2021-2032) & (US$ Million) Figure 55. Australia Aminoglycosides Antibiotics Drug Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Aminoglycosides Antibiotics Drug Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Aminoglycosides Antibiotics Drug Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Aminoglycosides Antibiotics Drug Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Aminoglycosides Antibiotics Drug Market Share by Country (2021-2032) Figure 60. Brazil Aminoglycosides Antibiotics Drug Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Aminoglycosides Antibiotics Drug Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Aminoglycosides Antibiotics Drug Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Aminoglycosides Antibiotics Drug Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Aminoglycosides Antibiotics Drug Market Size (2021-2032) & (US$ Million) Figure 65. UAE Aminoglycosides Antibiotics Drug Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Aminoglycosides Antibiotics Drug Market Size (2021-2032) & (US$ Million) Figure 67. Chile Aminoglycosides Antibiotics Drug Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Etimicin
  • Neomycin
  • Tobramycin
  • Gentamicin
  • Amikacin
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Teva
  • Novartis
  • Pfizer
  • Fresenius Kabi
  • Sun Pharma
  • Lannett Company
  • Jemicare
  • Hikma
  • Fangyuan-pharma
  • Cipla
  • Aike Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Aminoglycosides Antibiotics Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Etimicin
  5. 1.2.3 Neomycin
  6. 1.2.4 Tobramycin
  7. 1.2.5 Gentamicin
  8. 1.2.6 Amikacin
  9. 1.2.7 Others
  10. 1.3 Market Analysis by Application
  11. 1.3.1 Global Aminoglycosides Antibiotics Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  12. 1.3.2 Hospital
  13. 1.3.3 Clinic
  14. 1.3.4 Others
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Aminoglycosides Antibiotics Drug Growth Trends by Region
  17. 1.5.1 Global Aminoglycosides Antibiotics Drug Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Aminoglycosides Antibiotics Drug Market Size by Region (2021-2026)
  19. 1.5.3 Aminoglycosides Antibiotics Drug Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Aminoglycosides Antibiotics Drug Market Dynamics
  1. 2.1 Aminoglycosides Antibiotics Drug Industry Trends
  2. 2.2 Aminoglycosides Antibiotics Drug Industry Drivers
  3. 2.3 Aminoglycosides Antibiotics Drug Industry Opportunities and Challenges
  4. 2.4 Aminoglycosides Antibiotics Drug Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Aminoglycosides Antibiotics Drug Revenue by Company (2021-2026)
  2. 3.2 Global Aminoglycosides Antibiotics Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Aminoglycosides Antibiotics Drug Key Company Head office and Area Served
  4. 3.4 Global Aminoglycosides Antibiotics Drug Company, Product Type & Application
  5. 3.5 Global Aminoglycosides Antibiotics Drug Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Aminoglycosides Antibiotics Drug Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Aminoglycosides Antibiotics Drug Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Aminoglycosides Antibiotics Drug Tier 1, Tier 2, and Tier 3
4 Aminoglycosides Antibiotics Drug Market by Type
  1. 4.1 Global Aminoglycosides Antibiotics Drug Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Aminoglycosides Antibiotics Drug Market Size by Type (2021-2032)
  3. 4.3 Global Aminoglycosides Antibiotics Drug Market Size Share by Type (2021-2032)
5 Aminoglycosides Antibiotics Drug Market by Application
  1. 5.1 Global Aminoglycosides Antibiotics Drug Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Aminoglycosides Antibiotics Drug Market Size by Application (2021-2032)
  3. 5.3 Global Aminoglycosides Antibiotics Drug Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Aminoglycosides Antibiotics Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Teva Aminoglycosides Antibiotics Drug Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Aminoglycosides Antibiotics Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Novartis Aminoglycosides Antibiotics Drug Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Aminoglycosides Antibiotics Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Pfizer Aminoglycosides Antibiotics Drug Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Fresenius Kabi
  20. 6.4.1 Fresenius Kabi Company Information
  21. 6.4.2 Fresenius Kabi Business Overview
  22. 6.4.3 Fresenius Kabi Aminoglycosides Antibiotics Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Fresenius Kabi Aminoglycosides Antibiotics Drug Product Portfolio
  24. 6.4.5 Fresenius Kabi Recent Developments
  25. 6.5 Sun Pharma
  26. 6.5.1 Sun Pharma Company Information
  27. 6.5.2 Sun Pharma Business Overview
  28. 6.5.3 Sun Pharma Aminoglycosides Antibiotics Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Sun Pharma Aminoglycosides Antibiotics Drug Product Portfolio
  30. 6.5.5 Sun Pharma Recent Developments
  31. 6.6 Lannett Company
  32. 6.6.1 Lannett Company Company Information
  33. 6.6.2 Lannett Company Business Overview
  34. 6.6.3 Lannett Company Aminoglycosides Antibiotics Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Lannett Company Aminoglycosides Antibiotics Drug Product Portfolio
  36. 6.6.5 Lannett Company Recent Developments
  37. 6.7 Jemicare
  38. 6.7.1 Jemicare Company Information
  39. 6.7.2 Jemicare Business Overview
  40. 6.7.3 Jemicare Aminoglycosides Antibiotics Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Jemicare Aminoglycosides Antibiotics Drug Product Portfolio
  42. 6.7.5 Jemicare Recent Developments
  43. 6.8 Hikma
  44. 6.8.1 Hikma Company Information
  45. 6.8.2 Hikma Business Overview
  46. 6.8.3 Hikma Aminoglycosides Antibiotics Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Hikma Aminoglycosides Antibiotics Drug Product Portfolio
  48. 6.8.5 Hikma Recent Developments
  49. 6.9 Fangyuan-pharma
  50. 6.9.1 Fangyuan-pharma Company Information
  51. 6.9.2 Fangyuan-pharma Business Overview
  52. 6.9.3 Fangyuan-pharma Aminoglycosides Antibiotics Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Fangyuan-pharma Aminoglycosides Antibiotics Drug Product Portfolio
  54. 6.9.5 Fangyuan-pharma Recent Developments
  55. 6.10 Cipla
  56. 6.10.1 Cipla Company Information
  57. 6.10.2 Cipla Business Overview
  58. 6.10.3 Cipla Aminoglycosides Antibiotics Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Cipla Aminoglycosides Antibiotics Drug Product Portfolio
  60. 6.10.5 Cipla Recent Developments
  61. 6.11 Aike Pharmaceutical
  62. 6.11.1 Aike Pharmaceutical Company Information
  63. 6.11.2 Aike Pharmaceutical Business Overview
  64. 6.11.3 Aike Pharmaceutical Aminoglycosides Antibiotics Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Aike Pharmaceutical Aminoglycosides Antibiotics Drug Product Portfolio
  66. 6.11.5 Aike Pharmaceutical Recent Developments
7 North America
  1. 7.1 North America Aminoglycosides Antibiotics Drug Market Size (2021-2032)
  2. 7.2 North America Aminoglycosides Antibiotics Drug Market Size by Type
  3. 7.2.1 North America Aminoglycosides Antibiotics Drug Market Size by Type (2021-2026)
  4. 7.2.2 North America Aminoglycosides Antibiotics Drug Market Size by Type (2027-2032)
  5. 7.2.3 North America Aminoglycosides Antibiotics Drug Market Share by Type (2021-2032)
  6. 7.3 North America Aminoglycosides Antibiotics Drug Market Size by Application
  7. 7.3.1 North America Aminoglycosides Antibiotics Drug Market Size by Application (2021-2026)
  8. 7.3.2 North America Aminoglycosides Antibiotics Drug Market Size by Application (2027-2032)
  9. 7.3.3 North America Aminoglycosides Antibiotics Drug Market Share by Application (2021-2032)
  10. 7.4 North America Aminoglycosides Antibiotics Drug Market Size by Country
  11. 7.4.1 North America Aminoglycosides Antibiotics Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Aminoglycosides Antibiotics Drug Market Size by Country (2021-2026)
  13. 7.4.3 North America Aminoglycosides Antibiotics Drug Market Size by Country (2027-2032)
  14. 7.4.4 North America Aminoglycosides Antibiotics Drug Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Aminoglycosides Antibiotics Drug Market Size (2021-2032)
  2. 8.2 Europe Aminoglycosides Antibiotics Drug Market Size by Type
  3. 8.2.1 Europe Aminoglycosides Antibiotics Drug Market Size by Type (2021-2026)
  4. 8.2.2 Europe Aminoglycosides Antibiotics Drug Market Size by Type (2027-2032)
  5. 8.2.3 Europe Aminoglycosides Antibiotics Drug Market Share by Type (2021-2032)
  6. 8.3 Europe Aminoglycosides Antibiotics Drug Market Size by Application
  7. 8.3.1 Europe Aminoglycosides Antibiotics Drug Market Size by Application (2021-2026)
  8. 8.3.2 Europe Aminoglycosides Antibiotics Drug Market Size by Application (2027-2032)
  9. 8.3.3 Europe Aminoglycosides Antibiotics Drug Market Share by Application (2021-2032)
  10. 8.4 Europe Aminoglycosides Antibiotics Drug Market Size by Country
  11. 8.4.1 Europe Aminoglycosides Antibiotics Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Aminoglycosides Antibiotics Drug Market Size by Country (2021-2026)
  13. 8.4.3 Europe Aminoglycosides Antibiotics Drug Market Size by Country (2027-2032)
  14. 8.4.4 Europe Aminoglycosides Antibiotics Drug Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Aminoglycosides Antibiotics Drug Market Size (2021-2032)
  2. 9.2 China Aminoglycosides Antibiotics Drug Market Size by Type
  3. 9.2.1 China Aminoglycosides Antibiotics Drug Market Size by Type (2021-2026)
  4. 9.2.2 China Aminoglycosides Antibiotics Drug Market Size by Type (2027-2032)
  5. 9.2.3 China Aminoglycosides Antibiotics Drug Market Share by Type (2021-2032)
  6. 9.3 China Aminoglycosides Antibiotics Drug Market Size by Application
  7. 9.3.1 China Aminoglycosides Antibiotics Drug Market Size by Application (2021-2026)
  8. 9.3.2 China Aminoglycosides Antibiotics Drug Market Size by Application (2027-2032)
  9. 9.3.3 China Aminoglycosides Antibiotics Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Aminoglycosides Antibiotics Drug Market Size (2021-2032)
  2. 10.2 Asia Aminoglycosides Antibiotics Drug Market Size by Type
  3. 10.2.1 Asia Aminoglycosides Antibiotics Drug Market Size by Type (2021-2026)
  4. 10.2.2 Asia Aminoglycosides Antibiotics Drug Market Size by Type (2027-2032)
  5. 10.2.3 Asia Aminoglycosides Antibiotics Drug Market Share by Type (2021-2032)
  6. 10.3 Asia Aminoglycosides Antibiotics Drug Market Size by Application
  7. 10.3.1 Asia Aminoglycosides Antibiotics Drug Market Size by Application (2021-2026)
  8. 10.3.2 Asia Aminoglycosides Antibiotics Drug Market Size by Application (2027-2032)
  9. 10.3.3 Asia Aminoglycosides Antibiotics Drug Market Share by Application (2021-2032)
  10. 10.4 Asia Aminoglycosides Antibiotics Drug Market Size by Country
  11. 10.4.1 Asia Aminoglycosides Antibiotics Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Aminoglycosides Antibiotics Drug Market Size by Country (2021-2026)
  13. 10.4.3 Asia Aminoglycosides Antibiotics Drug Market Size by Country (2027-2032)
  14. 10.4.4 Asia Aminoglycosides Antibiotics Drug Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Aminoglycosides Antibiotics Drug Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Aminoglycosides Antibiotics Drug Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Aminoglycosides Antibiotics Drug Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Aminoglycosides Antibiotics Drug Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Aminoglycosides Antibiotics Drug Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Aminoglycosides Antibiotics Drug Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Aminoglycosides Antibiotics Drug Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Aminoglycosides Antibiotics Drug Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Aminoglycosides Antibiotics Drug Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Aminoglycosides Antibiotics Drug Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Aminoglycosides Antibiotics Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Aminoglycosides Antibiotics Drug Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Aminoglycosides Antibiotics Drug Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Aminoglycosides Antibiotics Drug Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst